Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway.

Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway.

Item
http://www.wikidata.org/entity/Q34888009
Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cellsExploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1/β-catenin/MMP-7 signaling pathwayIn Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells.The Zuo Jin Wan Formula Induces Mitochondrial Apoptosis of Cisplatin-Resistant Gastric Cancer Cells via Cofilin-1.Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1).Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells.Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cells.Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer.Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats.Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer.Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells.
P2860

Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway.

Item
http://www.wikidata.org/entity/Q34888009
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@ast
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@en
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@nl
type
label
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@ast
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@en
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@nl
prefLabel
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@ast
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@en
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Zuo Jin Wan reverses P-gp-medi ...... of the PI3K/Akt/NF-κB pathway.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932